// App-Quantinova.ai

P372 : Accelerated dosing schedule with ustekinumab in anti-TNF refractory Crohn`s disease

Researchers

Presenter

  • Aleman Gonzalez, H

Principal Investigators

  • Stamp, K

  • Whitehead, E

  • Pattinson, A

  • Turnbull, J

  • Myers, S

  • Talbot, A

  • Sebastian, S

Medical Centers

  • Hull University Teaching Hospitals, Inflammatory Bowel Disease, Kingston Upon Hull, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved